Envoy Medical Inc

Envoy Medical Inc(COCH)股票分析

$7.220

+0.122 (+1.69%)收盤時

Loading chart…
最高
7.240
開盤
7.050
成交量加權均價
7.12
成交量
50.47K
市值
44.88M
最低
6.900
成交金額
359.37K
企業價值/稅息折舊攤銷前利潤(TTM)
-1.23

Envoy Medical, Inc. is a hearing health company. The Company is engaged in providing medical technologies across the hearing loss spectrum, all designed to shift the paradigm within the hearing industry and bring both providers and patients the hearing devices they require. Its hearing solutions include hearing aids, middle ear implants, bone conduction devices and cochlear implants. The bone conduction hearing device has two components: an external component and a surgically implanted fixture placed in the bone behind the ear. Its bone conduction hearing device offers amplification without ear mold in the ear. Its hearing aids are devices that amplify sound for those with mild to moderate hearing loss. Its Esteem is a fully implanted active middle ear implant designed to improve the hearing of adults diagnosed with moderate to severe sensorineural hearing loss. Cochlear implants are a solution for people with moderate-to-profound sensorineural hearing loss.

AI 分析 of Envoy Medical Inc (COCH)

買進

Envoy Medical Inc is a good buy right now due to its recent performance and positive outlook. The current price is $6.65, which is significantly below the analyst price targets of $2.00 and $2.50, indicating a potential upside. Additionally, the stock has shown a remarkable year-to-date change of +855.87% and a 20-day change of +921.51%, reflecting strong momentum. However, the main risk is the negative earnings per share (EPS) estimate of -0.70 for the upcoming earnings report, which could impact investor sentiment.

估值指標

Envoy Medical Inc(COCH)目前預期本益比為 0.00,5 年平均預期本益比為 -1.83。

預期本益比

高估
5 年均值 P/E
-1.83
目前P/E
0.00
高估
-0.18
低估
-3.47

預期 EV/EBITDA

合理
5 年均值 EV/EBITDA
-1.22
目前EV/EBITDA
-1.23
高估
0.67
低估
-3.10

預期股價營收比

合理
5 年均值 P/S
113.45
目前P/S
201.61
高估
203.65
低估
23.26

Alphio AI 對 COCH 的價格情境

情境價格取自當年最後一個月度預測區間。機率為固定的模型權重(25 / 50 / 25),不構成保證。

樂

樂觀

樂觀 · 25%COCH

$1.15

情境價格

基

基準

基準 · 50%COCH

$1.10

情境價格

悲

悲觀

悲觀 · 25%COCH

$1.10

情境價格

事件時間軸

2026-10-26 (ET)

10:00:00

Envoy Medical Inc Trading Halted

2026-10-23 (ET)

20:00:00

Envoy Medical Inc Trading Halted, News Pending

2026-06-02 (ET)

08:50:00

Envoy Medical Signs Media Deal with New to The Street

2025-12-18 (ET)

17:30:00

Envoy Medical Files to Sell Class A Common Stock

2024-11-14 (ET)

07:42:28

Envoy Medical reports Q3 EPS (37c) vs. 13c last year.

資訊

COCH 常見問題 —— 由 Alphio AI 解答

Envoy Medical, Inc. is a hearing health company. The Company is engaged in providing medical technologies across the hearing loss spectrum, all designed to shift the paradigm within the hearing industry and bring both providers and patients the hearing devices they require. Its hearing solutions include hearing aids, middle ear implants, bone conduction devices and cochlear implants. The bone conduction hearing device has two components: an external component and a surgically implanted fixture placed in the bone behind the ear. Its bone conduction hearing device offers amplification without ear mold in the ear. Its hearing aids are devices that amplify sound for those with mild to moderate hearing loss. Its Esteem is a fully implanted active middle ear implant designed to improve the hearing of adults diagnosed with moderate to severe sensorineural hearing loss. Cochlear implants are a solution for people with moderate-to-profound sensorineural hearing loss. It operates in the Healthcare sector (ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUP industry).

Envoy Medical Inc is a good buy right now due to its recent performance and positive outlook. The current price is $6.65, which is significantly below the analyst price targets of $2.00 and $2.50, indicating a potential upside. Additionally, the stock has shown a remarkable year-to-date change of +855.87% and a 20-day change of +921.51%, reflecting strong momentum. However, the main risk is the negative earnings per share (EPS) estimate of -0.70 for the upcoming earnings report, which could impact investor sentiment.

暫無貼文

註冊或登入後參與討論

相關文章

本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。

開始交易